EMA – Open consultation: Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals
This Addendum to the guideline provides guidance on clinical studies to be conducted in immunocompromised individuals before or after initial marketing authorization of vaccines in order to support recommendations for use in the Product Information.
The deadline for the consultation is 31 October 2024.
More open consultations on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (19 octobre 2024). EMA – Open consultation: Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/12j9t





